Stockreport

Mesoblast to issue $50M convertible notes for product launch [Seeking Alpha]

Mesoblast Limited - American Depositary Shares  (MESO) 
US:NASDAQ Investor Relations: investorsmedia.mesoblast.com
PDF The agreement came on approval by the US FDA of Mesoblast's lead product candidate Ryoncil in the treatment of children with steroid-refractory acute graft versus host [Read more]